Skip to content

THE EFFICACY OF PAROXETINE AND COGNITIVE-BEHAVIOURAL THERAPY IN THE TREATMENT OF LATE-LIFE PANIC DISORDER: A RANDOMIZED CONTROLLED TRIAL.

THE EFFICACY OF PAROXETINE AND COGNITIVE-BEHAVIOURAL THERAPY IN THE TREATMENT OF LATE-LIFE PANIC DISORDER: A RANDOMIZED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23124
Enrollment
80
Registered
2007-11-27
Start date
1999-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Panic disorder

Interventions

3. A waiting-list control condition of 14 weeks. For both active treatments, paroxetine and CBT, follow-up period is 12 weeks.
1. Treatment with paroxetine 20 mg 1dd2 during 14 weeks
2. Cognitive behavioural therapy according to a treatment manual for panic disorder during 14 weekly sessions

Sponsors

1. Radboud University Nijmegen, Behavioural Science Institute, Nijmegen, the Netherlands: Prof. dr. C.A.L. Hoogduin, Dr. G.P.J. Keijsers; 2. GGz Nijmegen, Outpatient Department for Anxiety Disorders, Nijmegen PO Box 7049, 6503 GM Nijmegen, the Netherlands.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Panic disorder with/without agoraphobia (DSM-IV-criteria); 2. >60 years.

Exclusion criteria

Exclusion criteria: 1. The presence of severe psychiatric disorders (e.g. psychosis, major depression, bipolar disorder); 2. A severe somatic condition which would hinder appropriate application of CBT (e.g. severe cardiovascular disease); 3. A contraindication for prescribing paroxetine (e.g. co-occurring use of anti-coagulantia); 4. Current use of an antidepressant in an adequate dose; 5. Current and adequate psychological treatment; 6. Abuse or dependency of alcohol or psychoactive substances; 7. Dementia and a score of 23 or less on the Mini-Mental State Examination.

Design outcomes

Primary

MeasureTime frame
Self-report instruments for anxiety cogntions and phobic avoidance: scores on the Dutch adaptations of the Agoraphobic Cognitions Questionnaire (ACQ) and the Mobility Inventory avoidance scale (MI).

Secondary

MeasureTime frame
Self-report instruments for depression and general psychopathology. Depressive symptoms were assessed with the Dutch adaptation of the Beck Depression Inventory (BDI) and general psychopathology was assessed with the Dutch adaptation of the Symptom Checklist (SCL-90).

Contacts

Public ContactG.J. Hendriks

GGz Nijmegen, Outpatient Department for Anxiety Disorders, Nijmegen PO Box 7049,

ghendriks@ggznijmegen.nl+31-24-3837820

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)